Ethyl Acetate

Ethyl Acetate

SCHEMBL2624

CC(C)O.CCOC(C)=O

nearest known ligand 0.78

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.78
LMNA P02545 1/20 0.78
HSD17B10 Q99714 1/20 0.78
TSHR P16473 2/20 0.48
ALOX15 P16050 2/20 0.43
MGAM O43451 1/20 0.43
GAA P10253 1/20 0.43
SI P14410 1/20 0.43
MGAM2 Q2M2H8 1/20 0.43
SOAT1 P35610 1/20 0.43
TRPA1 O75762 1/20 0.40
GLO1 Q04760 1/20 0.39
CA12 O43570 2/20 0.38
CA1 P00915 2/20 0.38
CA2 P00918 2/20 0.38
CA9 Q16790 2/20 0.38
PGR P06401 1/20 0.37
CHRM2 P08172 1/20 0.37
CHRM4 P08173 1/20 0.37
HTR1A P08908 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethyl Acetate SCHEMBL14912846 1.00 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRALOX15
Ethyl Acetate SCHEMBL1006851 1.00 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRALOX15
Ethyl Acetate SCHEMBL15420019 1.00 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRALOX15
Ethyl Acetate SCHEMBL2210248 1.00 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRALOX15
Ethyl Acetate SCHEMBL18725338 1.00 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRALOX15
Ethyl Acetate SCHEMBL3227893 1.00 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRALOX15
Ethyl Acetate SCHEMBL11581471 1.00 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRALOX15
Ethyl Acetate SCHEMBL631255 1.00 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRALOX15
Ethyl Acetate SCHEMBL17329136 1.00 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRALOX15
Ethyl Acetate SCHEMBL6929783 1.00 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10TSHRALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1469 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115028530-B Extraction process of long-chain dibasic acid and long-chain dibasic acid product 上海凯赛生物技术股份有限公司 2024-11-26 CN claimed
CN-118894777-A Caffeic acid crystal form and preparation method thereof 德州德药制药有限公司 2024-11-05 CN claimed
CN-117865777-A Method and system for separating azeotropic system and method for separating mixed solution containing ethyl acetate-isopropanol 中国石油化工股份有限公司 2024-04-12 CN claimed
CN-116648121-B Vertical perovskite heterojunction film and continuous large-area preparation method and application thereof 长春理工大学 2023-10-13 CN claimed
CN-116648121-A Vertical perovskite heterojunction film and continuous large-area preparation method and application thereof 长春理工大学 2023-08-25 CN claimed
CN-114369050-B Preparation method of lutein ester 山东天音生物科技有限公司 2023-08-25 CN claimed
CN-114965735-B Multivariate statistical analysis method of aconite 神威药业集团有限公司 2023-04-25 CN claimed
CN-114965736-B High performance liquid chromatography detection method and high performance liquid chromatography tandem mass spectrometry combined detection method for aconite 神威药业集团有限公司 2023-04-21 CN claimed
CN-112710797-B Quality detection method for cough and asthma relieving pharmaceutical composition 贵州大隆药业有限责任公司 2023-04-07 CN claimed
CN-114965735-A Multivariate statistical analysis method of monkshood 神威药业集团有限公司 2022-08-30 CN claimed
JP-4791970-B2 2011-10-12 JP claimed
US-20100228228-A1 MEDICAL DEVICE FOR DISPERSING MEDICAMENTS BAYER INTELLECTUAL PROPERTY GMBH (DE) 2010-09-09 US claimed
CN-100582771-C Chinese medicinal soft capsule effective ingredient detection method RENHE DEV GROUP CO LTD 2010-01-20 CN claimed
US-20070179298-A1 Chemical process for the preparation of intermediates to obtain n-formyl hydroxy-lamine compounds NOVARTIS AG (CH) 2007-08-02 US claimed
US-20070135524-A1 Process for the preparation of polymorphs of selective serotonin reuptake inhibitor CIPLA LIMITED (IN) 2007-06-14 US claimed
CN-1836673-A Chinese medicinal soft capsule and method for preparing and controlling the quality of Chinese medicinal soft capsule RENHE DEV GROUP CO LTD (CN) 2006-09-27 CN claimed
EP-1682483-A2 PROCESS FOR THE PREPARATION OF POLYMORPHS OF SELECTIVE SEROTONIN REUPTAKE INHIBITOR Cipla Ltd. (IN) 2006-07-26 EP claimed
EP-1599440-A2 CHEMICAL PROCESS FOR THE PREPARATION OF INTERMEDIATES TO OBTAIN N-FORMYL HYDROXYLAMINE COMPOUNDS Novartis AG (CH) 2005-11-30 EP claimed
WO-2005047229-A2 PROCESS FOR THE PREPARATION OF POLYMORPHS OF SELECTIVE SEROTONIN REUPTAKE INHIBITOR CIPLA LIMITED (IN) 2005-05-26 WO claimed
WO-2004076053-A2 CHEMICAL PROCESS FOR THE PREPARATION OF INTERMEDIATES TO OBTAIN N-FORMYL HYDROXYLAMINE COMPOUNDS NOVARTIS AG (CH) 2004-09-10 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135524-A1 Process for the preparation of polymorphs of selective serotonin reuptake inhibitor SLC6A4, HTR5A, HTR3B ALDH1A1 1273/4885LMNA 1906/4885HSD17B10 950/4885
US-20070179298-A1 Chemical process for the preparation of intermediates to obtain n-formyl hydroxy-lamine compounds HAO1, LMNA, HAO2 ALDH1A1 765/4885LMNA 2/4885HSD17B10 98/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.